Timothy Ickes
Medical · Zanesville, OHNPI 1255585790
Payments from drug & device makers
Across 100 payments — averaging $16.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$425
- Alkermes, Inc.$297
- Sunovion Pharmaceuticals Inc.$171
- Corium, LLC$140
- Axsome Therapeutics, Inc.$121
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$88
- plus $390 from 13 others
What the payments were for
- Food & beverage$1,61599%
- Education$161%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 33 | $425 |
| Alkermes, Inc. | 12 | $297 |
| Sunovion Pharmaceuticals Inc. | 18 | $171 |
| Corium, LLC | 1 | $140 |
| Axsome Therapeutics, Inc. | 6 | $121 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $88 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $56 |
| QOL Medical, LLC | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Bayer | 2 | $36 |
| Lundbeck LLC | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| Novo Nordisk | 2 | $27 |
| Johnson & Johnson | 2 | $25 |
| Merck | 1 | $23 |
| Covis Pharma GmbH | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Azstarys$140
How this compares
$1,631 in reported general payments places this provider in the 70th percentile of 547 medical providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 17 | $7,676 |
| Aripiprazole | 71 | $6,828 |
| Buspirone Hcl | 98 | $2,745 |
| Vilazodone Hcl | 18 | $2,643 |
| Duloxetine Hcl | 73 | $1,975 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 15 | $1,505 |
| Divalproex Sodium ErDivalproex Sodium | 12 | $1,318 |
| Mirtazapine | 89 | $1,272 |
| Trazodone Hcl | 115 | $1,144 |
| Atomoxetine Hcl | 13 | $1,097 |
| Bupropion XlBupropion Hcl | 45 | $981 |
| Hydroxyzine Hcl | 53 | $710 |
| Hydroxyzine Pamoate | 40 | $485 |
| Prazosin Hcl | 13 | $480 |
| Amitriptyline Hcl | 16 | $466 |
Paid to pharmacies, not to this prescriber.
Other medical in Zanesville
- Shannon GhizzoniColumbus$116K
- Susan WhittCanal Winchester$74K
- Christopher FrickLima$46K
- Kodi VealeAkron$43K
- Abbey BlairCleveland$24K
- Joana ZulaConcord Twp$23K
- Chelsea AustenColumbus$21K
- Kristen FairchildToledo$19K
- Kaitlin SchuppGahanna$17K
- Melanie HunglerCincinnati$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.